AI and ultrasound join forces to spot muscle wasting in Brain-Injured ICU patients

NCT ID NCT07712198

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study tests whether artificial intelligence can predict muscle loss (sarcopenia) in intensive care patients with serious brain conditions like stroke, bleeding, or tumors. Researchers will measure thigh muscle thickness with ultrasound and track nutrition markers over the first week. They will then compare how well different AI models—ChatGPT, Gemini, and Claude—can forecast which patients develop muscle wasting. The goal is to see if AI can help doctors identify at-risk patients earlier, without any experimental treatment being given.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could enable early detection of muscle wasting in ICU patients, potentially guiding nutrition and physical therapy to improve recovery.
What could go wrong
This is an observational study with no intervention, so it cannot prove that AI predictions improve outcomes. Results may not apply to all ICU patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Trabzon University Faculty of Medicine, Kanuni Training and Research Hospital, Trabzon, 61080

    RECRUITING

    Trabzon, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.